Botulinum toxin type a therapy in migraine: preclinical and clinical trials (Q37631993)

21 August 2017

Botulinum toxin type a therapy in migraine: preclinical and clinical trials (English)

1 reference

21 August 2017

1 reference

botulinum toxin type A

1 reference

Yu-Feng Shao

1

1 reference

21 August 2017

Yi Zhang

2

1 reference

21 August 2017

Peng Zhao

3

1 reference

21 August 2017

Wen-Jun Yan

4

1 reference

21 August 2017

Xiang-Pan Kong

5

1 reference

21 August 2017

Lin-Lan Fan

6

1 reference

21 August 2017

Yi-Ping Hou

7

1 reference

21 August 2017

5 October 2013

1 reference

Iranian Red Crescent medical journal

21 August 2017

1 reference

21 August 2017

15

1 reference

21 August 2017

10

1 reference

21 August 2017

e7704

1 reference

Chronic migraine--classification, characteristics and treatment

21 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950781

Botulinum toxin type a for chronic migraine

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950781

Future drugs for migraine

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950781

Botulinum toxin type-A therapy in cluster headache: an open study

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950781

Long-term benefits of botulinum toxin type A (BOTOX) in chronic daily headache: a five-year long experience

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950781

Botulinum toxin in migraine prophylaxis

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950781

Synaptic transmission: inhibition of neurotransmitter release by botulinum toxins

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950781

The first world report of botulinum A toxin injection for status migrainosus

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950781

Neurogenic inflammation in the context of migraine

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950781

Substance P receptor antagonists in the therapy of migraine

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950781

Clinical and pathophysiological observations in migraine and tension-type headache explained by integration of vascular, supraspinal and myofascial inputs

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950781

Vitamin K acupuncture pint injection for severe primary dysmenorrhea: an international pilot study

23 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950781

Botulinum toxin: application into acupuncture points for migraine

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950781

A double-blind study of SB-220453 (Tonerbasat) in the glyceryltrinitrate (GTN) model of migraine.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950781

Extracranial blood flow, pain and tenderness in migraine. Clinical and experimental studies

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950781

Systemic nitroglycerin induces Fos immunoreactivity in brainstem and forebrain structures of the rat.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950781

Increase in plasma calcitonin gene-related peptide from the extracerebral circulation during nitroglycerin-induced cluster headache attack

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950781

Treating neurotic headache by point-injection with Novocain

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950781

Modulatory effects of probenecid on the nitroglycerin-induced changes in the rat caudal trigeminal nucleus

25 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950781

Botulinum toxin type A inhibits sensory neuropeptide release in rat bladder models of acute injury and chronic inflammation

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950781

Point injection as an alternative acupuncture technique--an exploratory study of responses in healthy subjects.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950781

Acupuncture needling versus lidocaine injection of trigger points in myofascial pain syndrome in elderly patients--a randomised trial

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950781

Botulinum toxin therapy in the ovalbumin-sensitized rat.

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950781

The effect of propranolol on glyceryltrinitrate-induced headache and arterial response

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950781

Clinical recognition of allodynia in migraine

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950781

A case series of temporomandibular disorders treated with acupuncture, occlusal splint and point injection therapy

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950781

Therapeutic Effects of <i>Hominis placenta</i> Injection into an Acupuncture Point on the Inflammatory Responses in Subchondral Bone Region of Adjuvant-Induced Polyarthritic Rat

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950781

An association between migraine and cutaneous allodynia

1 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3950781

Cost-effectiveness of acupuncture treatment in patients with headache

1 September 2018

1 reference

12 December 2020

Pressure pain threshold and needle acupuncture in chronic tension-type headache--a double-blind placebo-controlled study

1 reference

12 December 2020

Botulinum toxin type A inhibits rat pyloric myoelectrical activity and substance P release in vivo

1 reference

12 December 2020

Predictors of response to botulinum toxin type A (BoNTA) in chronic daily headache

1 reference

12 December 2020

Nuclear medicine and acupuncture message transmission

1 reference

12 December 2020

Nitroglycerin enhances cGMP expression in specific neuronal and cerebrovascular structures of the rat brain

1 reference

12 December 2020

Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential

1 reference

12 December 2020

Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group

1 reference

12 December 2020

Single-site botulinum toxin type a injection for elimination of migraine trigger points

1 reference

12 December 2020

Identifiers

DOI

10.5812/IRCMJ.7704

1 reference

21 August 2017

1 reference

21 August 2017

PubMed publication ID

24693369

1 reference